Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
The BIB Wine Company is, according to the Independent, the first-ever luxury Bag-in-Box wine company. The BIB Wine Company has received excellent reviews from critics and has been given a 4.6 stars rating on reviews.co.uk. The company's Head of Wine has previously headed up wine at Waitrose & Laithwaites. It has sold an equivalent of more than 11,400 bottles in the first year of production. In August 2019, the company's YoY growth hit 200%. The BIB Wine Company has also been nominated for two category awards in the People's Choice Wine Awards. With the proceeds, the company will increase the digital spend to local workers and residents.
days to go:
Expired
investment:
£189,695
We created FlyFit with the aim to change the way people travel. Air travel can be stressful, lonely, and unhealthy. On top of this, with average layovers of 2+ hours, flight delays, and hours waiting in security, there is too much unproductive time in airports with limited healthy options to choose from.
days to go:
Expired
investment:
£500,060
Genuine Impact is the next generation financial terminal made exclusively to empower DIY investors by providing experts with automation tools, portfolio enhancer, unbiased data and insights. Genuine Impact is more cost-effective in comparison with traditional financial terminals, and it makes financial research effortless and efficient. Currently, the company's beta app has 500+ users from more than 27 countries. With the proceeds, the fund raised will be used for new product development, enhancement of existing product and for marketing and branding.
days to go:
Expired
investment:
£500,920
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
A financial assistant that helps you to save and invest money all from within an app. Plum connects to your existing bank account and uses machine learning to save money you're not spending every month by looking at your transactions history, without any input required.
days to go:
Expired
investment:
£1,005,249
